Advertisement
YOU ARE HERE: LAT HomeCollections

Business Briefing / COURTS

Roche is barred from selling drug

October 11, 2008|From Times Wire Services

Roche Holding was barred by an appeals court from selling the anemia drug Mircera in the U.S. after a judge found that the Swiss company infringed patents held by Thousand Oaks-based Amgen Inc.

The U.S. Court of Appeals for the Federal Circuit upheld a February order by U.S. District Judge William Young in Boston without comment. Young ruled last week that U.S. sales of Mircera should be blocked until the patents expire.

Advertisement
Los Angeles Times Articles
|
|
|